• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

专利法——平衡利润最大化与公众对技术的获取。

Patent law--balancing profit maximization and public access to technology.

作者信息

Beckerman-Rodau Andrew

机构信息

Suffolk University Law School, Boston, MA, USA.

出版信息

Columbia Sci Technol Law Rev. 2003;4:E1.

PMID:15977333
Abstract

This article addresses the contemporary issue of balancing the need for patent protection for intellectual property with the resulting restriction of public access to new technology. The author argues that patent law protects private property rights rather than creating monopolies. Additionally, the author discusses how restricting access to patented technology, such as pharmaceuticals, can affect public health problems, such as the HIV/AIDS epidemic in developing nations. The author then concludes with some proposals for making patented technology available to people in developing nations who need access to such technology but who are unable to afford its high costs due to patent protection.

摘要

本文探讨了一个当代问题,即如何在保护知识产权所需的专利保护与由此导致的公众获取新技术受限之间取得平衡。作者认为,专利法保护的是私有财产权,而非制造垄断。此外,作者还讨论了限制获取专利技术(如药品)会如何影响公共卫生问题,例如发展中国家的艾滋病毒/艾滋病疫情。作者随后提出了一些建议,以使专利技术能够提供给发展中国家那些需要此类技术但因专利保护而无力承担其高昂成本的人们。

相似文献

1
Patent law--balancing profit maximization and public access to technology.专利法——平衡利润最大化与公众对技术的获取。
Columbia Sci Technol Law Rev. 2003;4:E1.
2
Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.知识产权、世界贸易组织与公共卫生:巴西视角
Conn J Int Law. 2002 Spring;17(2):311-8.
3
Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.耐药性、专利耐药性:印度制药业与新专利制度的影响。
Glob Public Health. 2009;4(6):515-27. doi: 10.1080/17441690902796449.
4
Access to essential medicines: a Hobbesian social contract approach.基本药物的可及性:一种霍布斯式社会契约方法
Dev World Bioeth. 2005 May;5(2):121-41. doi: 10.1111/j.1471-8847.2005.00108.x.
5
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取:从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
6
Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.专利必要性:生物技术领域的知识产权困境与发展中国家的治疗公平性
Houst J Int Law. 2002;24(2):227-78.
7
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?《与贸易有关的知识产权协定》(TRIPS协定)在拉丁美洲和加勒比地区的实施是否产生了有利于公共卫生的知识产权立法?
Bull World Health Organ. 2004 Nov;82(11):815-21. Epub 2004 Dec 14.
8
Balancing pills and patents: intellectual property and the HIV/AIDS crisis.权衡药物与专利:知识产权与艾滋病毒/艾滋病危机
E Law. 2001 Sep;8(3):E5.
9
Access to essential drugs, human rights and global justice.基本药物的可及性、人权与全球正义。
Monash Bioeth Rev. 2004 Jan;23(1):S56-74.
10
The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.信息革命触及制药行业:在后基因组时代平衡创新激励、成本与可及性。
Univ Ill Law Rev. 2001;2001(1):173-210.